Epilepsy Market

Feb 04, 2021

10 likes | 19 Views

Epilepsy is a neurological disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, and sometimes loss of awareness. As per the Delveinsight, in 2017, the Epilepsy market size in 7MM was USD 1,847.46 Million. The total prevalent population of Epilepsy in 7MM was 7,190,297 in 2017. The total prevalent population of Epilepsy in the United States was found to be 3,579,732, while the United Kingdom and Germany had a prevalent population of 3,579,732 and 641,720 respectively. Specialized multidisciplinary care, constructive efforts, promising emerging therapies, increase in R&D and government initiatives and funding are the key drivers for the Epilepsy market. Some of the key companies in the Epilepsy market include Marinus Pharmaceuticals, Aquestive Therapeutics, Insys Therapeutics, Takeda/Ovid Therapeutics, Zynerba Pharma, Idorsia Pharmaceuticals, Neurocrine Biosciences, PTC Therapeutics, BioPharm Solutions, Biogen, Engage Therapeutics, Cerebral Therapeutics, Epygenix, Jazz Pharmaceuticals, Xenon Pharmaceuticals, Pfizer/ Cerevel Therapeutics, and Stoke Therapeutics. Source: Epilepsy Market

DelveInsight

Download Presentation

Epilepsy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D